| # | Drug | Count |
|---|---|---|
| 0 | ESTRADIOL | 36 |
| 1 | ESTRADIOL GEL 0.1% | 11 |
| 2 | ESTRADIOL TRANSDERMAL | 11 |
| 3 | ESTRADIOL, | 11 |
| 4 | BRINZOLAMIDE/BRIMONIDINE TARTRATE | 8 |
| 5 | TESTOSTERONE | 8 |
| 6 | BUPRENORPHINE | 7 |
| 7 | NEPAFENAC | 7 |
| 8 | ASPIRIN | 6 |
| 9 | ASPIRIN 325 MG | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLASCOTERONE | 4 | 0.0028 |
| 1 | NEPAFENAC | 7 | 0.0022 |
| 2 | BRINZOLAMIDE/BRIMONIDINE TARTRATE | 8 | 0.0019 |
| 3 | ESTRADIOL ACETATE | 1 | 0.0013 |
| 4 | 12%AZELAIC ACID | 1 | 0.0012 |
| 5 | AZELAIC ACID | 1 | 0.0010 |
| 6 | ESTRADIOL | 36 | 0.0004 |
| 7 | INSULIN ASPART INJECTION | 1 | 0.0004 |
| 8 | PRASTERONE | 1 | 0.0004 |
| 9 | ESTROGEN | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 42 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 2 | Androgen [EPC] | 8 |
| 3 | Carbonic Anhydrase Inhibitor [EPC] | 8 |
| 4 | Partial Opioid Agonist [EPC] | 7 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 6 |
| 6 | Androgen Receptor Inhibitor [EPC] | 4 |
| 7 | Benzodiazepine [EPC] | 3 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 3 |
| 9 | Provitamin D2 Compound [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbonic Anhydrase Inhibitor [EPC] | 8 | 0.0004 |
| 1 | Androgen [EPC] | 8 | 0.0003 |
| 2 | Estrogen [EPC] | 42 | 0.0002 |
| 3 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 5 | Partial Opioid Agonist [EPC] | 7 | 0.0001 |
| 6 | Androgen Receptor Inhibitor [EPC] | 4 | 0.0001 |
| 7 | Progesterone [EPC] | 1 | 0.0000 |
| 8 | Tetracycline-class Drug [EPC] | 2 | 0.0000 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 3 | 0.0000 |